371
Views
0
CrossRef citations to date
0
Altmetric
Research Article

In vitro evaluation of curcumin-loaded chitosan-coated hydroxyapatite nanocarriers as a potential system for effective treatment of cancer

, , &
Pages 1267-1287 | Received 11 Feb 2021, Accepted 28 Mar 2021, Published online: 19 Apr 2021

References

  • Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):71.
  • Ahmadkhani L, Mostafavi E, Ghasemali S, et al. Development and characterization of a novel conductive polyaniline-g-polystyrene/Fe3O4 nanocomposite for the treatment of cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):873–881.
  • Nagaraju GP, Srivani G, Dariya B, et al. Nanoparticles guided drug delivery and imaging in gastric cancer. Semin Cancer Biol. 2020.
  • Pant P, Gupta C, Kumar S, et al. Curcumin loaded silica nanoparticles and their therapeutic applications: a review. J Mater Nanosci. 2020;7(1):1–18.
  • Chen M, Zhou X, Chen R, et al. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Mater Today. 2019;25:66–87.
  • Song X, Gan K, Qin S, et al. Preparation and characterization of general-purpose gelatin-based co-loading flavonoids nano-core structure. Sci Rep. 2019;9(1):1–11.
  • Aghdam MA, Bagheri R, Mosafer J, et al. Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release. J Control Release. 2019;315:1–22.
  • Ashjaran M, Babazadeh M, Akbarzadeh A, et al. Stimuli-responsive polyvinylpyrrolidone-NIPPAm-lysine graphene oxide nano-hybrid as an anticancer drug delivery on MCF7 cell line. Artif Cells Nanomed Biotechnol. 2019;47(1):443–454.
  • Castillo RR, Lozano D, González B, et al. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update. Expert Opin Drug Deliv. 2019;16(4):415–439.
  • Jain KK. An overview of drug delivery systems. Drug Deliv Syst. 2020;1–54.
  • Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA A Cancer J Clin. 2019;69(5):363–385.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
  • Dai Q, Geng H, Yu Q, et al. Polyphenol-based particles for theranostics. Theranostics. 2019;9(11):3170–3190.
  • Sajadimajd S, Bahramsoltani R, Iranpanah A, et al. Advances on natural polyphenols as anticancer agents for skin cancer. Pharmacol Res. 2020;151:104584.
  • Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017;57(13):2889–2895.
  • Martinez-Correa HA, Paula JT, Kayano AV, et al. Composition and antimalarial activity of extracts of Curcuma longa L. obtained by a combination of extraction processes using supercritical CO2, ethanol and water as solvents. J Supercrit Fluids. 2017;119:122–129.
  • Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014;46(1):2–18.
  • Liu W, Zhai Y, Heng X, et al. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016;24(8):694–702.
  • Zeng X, Cai D, Zeng Q, et al. Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in rat. Biopharm Drug Dispos. 2017;38(1):3–19.
  • Arshad L, Haque MA, Abbas Bukhari SN, et al. An overview of structure-activity relationship studies of curcumin analogs as antioxidant and anti-inflammatory agents. Future Med Chem. 2017;9(6):605–626.
  • Panda AK, Chakraborty D, Sarkar I, et al. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol. 2017;9:31–45.
  • Li R, Deng L, Cai Z, et al. Liposomes coated with thiolated chitosan as drug carriers of curcumin. Mater Sci Eng C Mater Biol Appl. 2017;80:156–164.
  • Ganjali M, Ganjali M, Nasab NA. Cytotoxic effects of laser-synthesized silver nanoparticles on human breast adenocarcinoma cells. Mater Today Proc. 2018;5(7):15567–15572.
  • Soltani B, Nabipour H, Nasab NA. Efficient storage of gentamicin in nanoscale zeolitic imidazolate framework-8 nanocarrier for pH-responsive drug release. J Inorg Organomet Polym. 2018;28(3):1090–1097.
  • Ramazani A, Abrvash M, Sadighian S, et al. Preparation and characterization of curcumin loaded gold/graphene oxide nanocomposite for potential breast cancer therapy. Res Chem Intermed. 2018;44(12):7891–7904.
  • Rostamizadeh K, Rezaei S, Abdouss M, et al. A hybrid modeling approach for optimization of PMAA–chitosan–PEG nanoparticles for oral insulin delivery. RSC Adv. 2015;5(85):69152–69160.
  • Sadighian S, Rostamizadeh K, Hosseini M-J, et al. Magnetic nanogels as dual triggered anticancer drug delivery: toxicity evaluation on isolated rat liver mitochondria. Toxicol Lett. 2017;278:18–29.
  • Mittal R, Patel AP, Jhaveri VM, et al. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opin Drug Deliv. 2018;15(3):301–318. Mar
  • Iafisco M, Varoni E, Di Foggia M, et al. Conjugation of hydroxyapatite nanocrystals with human immunoglobulin G for nanomedical applications. Colloids Surf B Biointerfaces. 2012;90:1–7.
  • Li H, Sun X, Li Y, et al. Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier. Mater Sci Eng C Mater Biol Appl. 2019;97:222–229.
  • Sun Q, Bi H, Wang Z, et al. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy. Biomaterials. 2019;223:119473.
  • Ye Y, Zhang D, Li J, et al. One-step synthesis of superhydrophobic polyhedral oligomeric silsesquioxane-graphene oxide and its application in anti-corrosion and anti-wear fields. Corros Sci. 2019;147:9–21.
  • Ye Y, Zhang D, Liu T, et al. Superior corrosion resistance and self-healable epoxy coating pigmented with silanzied trianiline-intercalated graphene. Carbon. 2019;142:164–176.
  • Song S, Shen H, Wang Y, et al. Biomedical application of graphene: from drug delivery, tumor therapy, to theranostics. Colloids Surf B Biointerfaces. 2020;185:110596.
  • Saleemi MA, Kong YL, Yong PVC, et al. An overview of recent development in therapeutic drug carrier system using carbon nanotubes. J Drug Deliv Sci Technol. 2020;59:101855.
  • Liu L, Jiang H, Dong J, et al. PEGylated MoS2 quantum dots for traceable and pH-responsive chemotherapeutic drug delivery. Colloids Surf B Biointerfaces. 2020;185:110590.
  • Manzano M, Vallet‐Regí M. Mesoporous silica nanoparticles for drug delivery. Adv Funct Mater. 2020;30(2):1902634.
  • Ye Y, Chen H, Zou Y, et al. Corrosion protective mechanism of smart graphene-based self-healing coating on carbon steel. Corros Sci. 2020;174:108825.
  • Zhou Y, Wang Y, Wang K, et al. Hybrid genetic algorithm method for efficient and robust evaluation of remaining useful life of supercapacitors. Appl Energy. 2020;260:114169.
  • Sathiyavimal S, Vasantharaj S, LewisOscar F, et al. Biosynthesis and characterization of hydroxyapatite and its composite (hydroxyapatite-gelatin-chitosan-fibrin-bone ash) for bone tissue engineering applications. Int J Biol Macromol. 2019;129:844–852.
  • Varadavenkatesan T, Vinayagam R, Pai S, et al. Synthesis, biological and environmental applications of hydroxyapatite and its composites with organic and inorganic coatings. Prog Org Coatings. 2021;151:106056.
  • Sathiyavimal S, Vasantharaj S, LewisOscar F, et al. Natural organic and inorganic–hydroxyapatite biopolymer composite for biomedical applications. Prog Org Coatings. 2020;147:105858.
  • Shen L-C, Chen Y-K, Lin L-M, et al. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma – in vitro and in vivo studies. Oral Oncol. 2010;46(3):178–184.
  • Lee W-H, Loo C-Y, Rohanizadeh R. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles. Mater Sci Eng C Mater Biol Appl. 2019;99:929–939.
  • Sabra R, Roberts CJ, Billa N. Courier properties of modified citrus pectinate-chitosan nanoparticles in colon delivery of curcumin. Colloid Interface Sci Commun. 2019;32:100192.
  • Desbrieres J, Peptu C, Ochiuz L, et al. Application of chitosan-based formulations in controlled drug delivery. In: Crini G, Lichtfouse E, editors. Sustainable agriculture reviews. Vol. 36. Cham: Springer; 2019. p. 241–314.
  • Kazempour M, Namazi H, Akbarzadeh A, et al. Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier. Artif Cells Nanomed Biotechnol. 2019;47(1):90–94.
  • Sathiyavimal S, Vasantharaj S, Kaliannan T, et al. Eco-biocompatibility of chitosan coated biosynthesized copper oxide nanocomposite for enhanced industrial (Azo) dye removal from aqueous solution and antibacterial properties. Carbohydr Polym. 2020;241:116243.
  • Shanmuganathan R, Edison TNJI, LewisOscar F, et al. Chitosan nanopolymers: an overview of drug delivery against cancer. Int J Biol Macromol. 2019;130:727–736.
  • Samuel MS, Suman S, Venkateshkannan Selvarajan E, et al. Immobilization of Cu3(btc)2 on graphene oxide-chitosan hybrid composite for the adsorption and photocatalytic degradation of methylene blue. J Photochem Photobiol B Biol. 2020;204:111809.
  • Bi Y-G, Lin Z-T, Deng S-T. Fabrication and characterization of hydroxyapatite/sodium alginate/chitosan composite microspheres for drug delivery and bone tissue engineering. Mater Sci Eng C Mater Biol Appl. 2019;100:576–583.
  • Paul P, Kolesinska B, Sujka W. Chitosan and its derivatives – biomaterials with diverse biological activity for manifold applications. Mini Rev Med Chem. 2019;19(9):737–750.
  • Ahmadi Nasab N, Hassani Kumleh H, Beygzadeh M, et al. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif Cells Nanomed Biotechnol. 2018;46(1):75–81.
  • Nabipour H, Soltani B, Ahmadi Nasab N. Gentamicin loaded Zn2(bdc)2(dabco) frameworks as efficient materials for drug delivery and antibacterial activity. J Inorg Organomet Polym. 2018;28(3):1206–1213.
  • Saeidifar M, Mirzaei H, Ahmadi Nasab N, et al. Mononuclear Pd(II) complex as a new therapeutic agent: synthesis, characterization, biological activity, spectral and DNA binding approaches. J Mol Struct. 2017;1148:339–346.
  • Soltani B, Nabipour H, Ahmadi Nasab N. Fabrication, controlled release, and kinetic studies of indomethacin—layered zinc hydroxide nanohybrid and its effect on the viability of HFFF2. J Dispers Sci Technol. 2018;39(8):1200–1207.
  • Shahraki S, Heidari A, Mirzaei HR, et al. Synthesis, characterization, cytotoxicity, DNA binding and computational studies of an anionic palladium(II) complex derived from 8-hydroxyquinoline and 1,1-cyclobutanedicarboxylate. J Iran Chem Soc. 2018;15(3):697–709.
  • Nosrati H, Abhari F, Charmi J, et al. Facile green synthesis of bismuth sulfide radiosensitizer via biomineralization of albumin natural molecule for chemoradiation therapy aim. Artif Cells Nanomed Biotechnol. 2019;47(1):3832–3838.
  • Nezafati N, Farokhi M, Heydari M, et al. In vitro bioactivity and cytocompatibility of an injectable calcium phosphate cement/silanated gelatin microsphere composite bone cement. Compos Part B Eng. 2019;175:107146.
  • Venkatesan P, Puvvada N, Dash R, et al. The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer. Biomaterials. 2011;32(15):3794–3806.
  • Lee W-H, Loo C-Y, Traini D, et al. Development and evaluation of paclitaxel and curcumin dry powder for inhalation lung cancer treatment. Pharmaceutics. 2021;13(1):9.
  • Uskoković V, Desai TA. In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis. J Pharm Sci. 2014;103(2):567–579.
  • Jogiya B, Chudasama K, Thaker V, et al. Synthesis and characterization of novel bio-material: nano composites of hydroxyapatite and curcumin. Int J Appl Ceram Technol. 2018;15(1):148–160.
  • Sahu A, Bora U, Kasoju N, et al. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater. 2008;4(6):1752–1761.
  • Zhang Y, Yang C, Wang W, et al. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep. 2016;6:21225.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.